These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6939949)

  • 41. [Cytotoxic antibodies to leukemia cells in normal human sera].
    Dorè JF; Bertoglio J; Guibout C
    Ann Immunol (Paris); 1977; 128(1-2):155-7. PubMed ID: 265695
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody.
    Ball ED; Graziano RF; Fanger MW
    J Immunol; 1983 Jun; 130(6):2937-41. PubMed ID: 6574189
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunological studies in acute leukemia.
    Santos GW; Anderson PN; Klein DL; Bias WB; Schacter BZ; Mullins GM; Burke PJ
    Trans Am Clin Climatol Assoc; 1977; 88():95-107. PubMed ID: 143105
    [No Abstract]   [Full Text] [Related]  

  • 44. Human granulocyte antigens detected on leukemia cells and a chronic myelogenous cell line.
    Drew SI; Billing R; Bergh OJ; Terasaki PI
    Vox Sang; 1978; 34(1):1-7. PubMed ID: 74903
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Leukemic myeloblasts expressing lymphoid markers.
    Reizenstein P; Beksac M; Biberfeld P; Christensson B; Lagerlöf B; Laurén L; Ost A; Porwit A
    Acta Haematol; 1985; 74(3):148-50. PubMed ID: 2937254
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Monoclonal antibodies reactive with human myeloid leukaemia cells.
    Ball ED; Fanger MW
    Clin Exp Immunol; 1982 Jun; 48(3):655-65. PubMed ID: 6956470
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Staging of leukemic progenitor cells in acute myeloid leukemia by phenotyping with myeloid monoclonal antibodies.
    Hast R; Dowding C; Robak T; Goldman JM
    Exp Hematol; 1986 Nov; 14(10):981-7. PubMed ID: 3464449
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Acute myelogenous leukemia: trial therapy with a myxovirus adapted to myeloblasts].
    Sauter C; Gerber A; Lindenmann J; Martz G
    Schweiz Med Wochenschr; 1972 Mar; 102(9):285-90. PubMed ID: 4501808
    [No Abstract]   [Full Text] [Related]  

  • 49. [Detection of B-cell antigen on the blast cells in chronic myeloid leukemia].
    Morozova LF; Belianchikova NI; Radzikhovskaia RM; Baryshnikov AIu; Volkova MA
    Biull Eksp Biol Med; 1979 Jun; 87(6):574-6. PubMed ID: 380683
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunity in leukemia.
    Gatti RA
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:275-81. PubMed ID: 4277522
    [No Abstract]   [Full Text] [Related]  

  • 51. Antibody dependent cellular cytotoxicity and complement mediated cytotoxicity on leukemic cells mediated by anti K562 monoclonal antibodies.
    Tatake RJ; Maniar HS; Chiplunkar SV; Somasundaram R; Amin MK; Saikia T; Gangal SG
    J Clin Lab Immunol; 1990 Feb; 31(2):87-91. PubMed ID: 1966990
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Detection of an antigen, associated with cells during the blast crisis of chronic myeloleukemia, in a cytotoxic test using xenogenic antibodies].
    Baryshnikov AIu; Radzikhovskaia RM; Morozova LF; Slavina EG; Belianchikova NI
    Biull Eksp Biol Med; 1977 Jun; 83(6):719-21. PubMed ID: 267492
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Studies on specific humoral immunity in leukemia.
    Bergolz VM
    Neoplasma; 1976; 23(5):457-62. PubMed ID: 790209
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Demonstration of a specific immune response against leukemia-associated antigens in patients with acute myeloblastic leukemia in full remission by means of the leukocyte adherence inhibition test].
    Voigtmann R; Hirschmann WD; Gerecke D; Kaulen HD; Gross R
    Verh Dtsch Ges Inn Med; 1978; (84):180-4. PubMed ID: 283637
    [No Abstract]   [Full Text] [Related]  

  • 55. Serological detection of B-cell ("Ia-like") antigens in serum of normal donor and in some sera of leukaemic patients.
    Koubek K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(3):408-15. PubMed ID: 6182060
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Platelet-induced tolerance in the production of heteroantisera to human leukemia-associated antigens.
    Baker MA; Taub RN
    J Immunol Methods; 1976 Mar; 10(2-3):171-5. PubMed ID: 1064673
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human leukemia-associated anti-nuclear reactivity.
    Klein G; Steiner M; Wiener F; Klein E
    Proc Natl Acad Sci U S A; 1974 Mar; 71(3):685-9. PubMed ID: 4595570
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Leukemia associated antigen].
    Berg K; Stavem P
    Tidsskr Nor Laegeforen; 1974 Nov; 94(32):2214-6. PubMed ID: 4531115
    [No Abstract]   [Full Text] [Related]  

  • 59. Acute lymphocytic leukemia-associated cell membrane antigen.
    Billing R; Minowada J; Cline M; Clark B; Lee K
    J Natl Cancer Inst; 1978 Aug; 61(2):423-9. PubMed ID: 308102
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction and specificity of syngeneic antiserum against Rauscher murine leukemia virus-induced leukemia, RBL-5.
    Alaba O; Law LW
    Int J Cancer; 1980 Aug; 26(2):217-25. PubMed ID: 7203714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.